PPAR gamma agonists for treatment of multiple sclerosis
View Patent ↗Methods of treatment of multiple sclerosis (MS) with PPARγ agonists, and in particular with the compound of formula (I) known as INT131:
1. A method of treating relapsing and remitting multiple sclerosis (RRMS) in a patient in need thereof at a regular dosing interval comprising administering to said patient a pharmaceutical composition comprising from about 1 to about 3 milligrams of a compound of formula (I),
or a pharmaceutically acceptable salt, prodrug, or isomer thereof.
2. The method of claim 1 wherein said administering the compound of formula (I) is about 3 milligrams per day.
3. The method of claim 1 , wherein said regular dosing interval is once per day.
4. A method of treating the symptoms of relapsing and remitting multiple sclerosis (RRMS) comprising administering to a patient in need thereof at a regular dosing interval from about 1 to about 3 milligrams of a compound of formula (I),
or a pharmaceutically acceptable salt, prodrug or isomer thereof.
5. The method of claim 4 wherein said administering the compound of formula (I) is about 3 milligrams per day.
6. The method of claim 4 , wherein said regular dosing interval is once per day.